Wednesday, May 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

APG’s Chemical Biological Defense APBI

by Global Biodefense Staff
September 18, 2015

The U.S. Army’s Aberdeen Proving Ground (APG) will host the fourth annual Advanced Planning Briefing to Industry on November 3-5, 2015.

The goal of the event is to provide the industrial base with networking opportunities and information on upcoming and long term potential contracting opportunities for mission areas that focus on: Chemical/Biological Defense (CBD); Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance (C4ISR); Research and Development (R&D); and APG Garrison Services.

The APBI will discuss potential contracting opportunities that are closely aligned with the technology roadmaps of each respective organization, specifically focusing on Fiscal Years 2016 and 2017 opportunities.

The CBD portion of the APBI will take place on Nov. 5, with presentations from the following organizations:

  • Program Executive Office for Chemical and Biological Defense (JPEO CBD)
  • Edgewood Chemical Biological Center
  • Defense Threat Reduction Agency (DTRA) – Joint Science and Technology Office
  • US Army Medical Research Institute for Chemical Defense (USAMRICD)
  • Chemical Materials Activity

The government announcement states that the APBI is subject to conference approval and funding and only constitutes a ‘Save-the-Date’ at this time.

The APBI will be unclassified and open to all interested contractors, large and small businesses, and academia as well as other government stakeholders. Slides from the APBI will be made available following the event.

Editor’s Note: The APBI announcement was updated on 5 Oct to confirm the event is going forward, and no longer listed as a “save-the-date” pending funding approvals.

Tags: Events

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC